Response to the Critical Comments on the Article “Infant Death due to Cannabis Ingestion”
Drug Testing and Analysis · 2026-06 · 18 (6) · 717-718
DOI: 10.1002/dta.70055 ↗Kurz gefasst
Leserbrief in der Zeitschrift Drug Testing and Analysis, online erschienen am 25.03.2026. Verfasst von Donata Favretto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Legal Medicine and Toxicology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, Padua, Italy.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Legal Medicine and Toxicology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, Padua, Italy.
- Specialist in Legal Medicine, Portogruaro, Italy.
- Specialist in Legal Medicine, Padua, Italy.
- Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University Hospital of Padua, Padua, Italy.
ORCID-Profile: Donata Favretto
Zitieren
APA
Favretto, D., Cirnelli, A., Pertile, R., Stimamiglio, R., Cestonaro, C., Pagliaro, A., Mattiazzi, F., Cuman, O., Basso, C., & Galeazzi, M. (2026). Response to the Critical Comments on the Article “Infant Death due to Cannabis Ingestion”. Drug Testing and Analysis, 18(6), 717-718. https://doi.org/10.1002/dta.70055
Vancouver
Favretto D, Cirnelli A, Pertile R, Stimamiglio R, Cestonaro C, Pagliaro A, et al. Response to the Critical Comments on the Article “Infant Death due to Cannabis Ingestion”. Drug Testing and Analysis. 2026;18(6):717-718. doi:10.1002/dta.70055
BibTeX
@article{Favretto2026,
author = {Favretto, Donata and Cirnelli, Antonello and Pertile, Roberto and Stimamiglio, Raffaella and Cestonaro, Clara and Pagliaro, Anna and Mattiazzi, Fabio and Cuman, Oriana and Basso, Cristina and Galeazzi, Maddalena},
title = {Response to the Critical Comments on the Article “Infant Death due to Cannabis Ingestion”},
journal = {Drug Testing and Analysis},
year = {2026},
volume = {18},
number = {6},
pages = {717--718},
doi = {10.1002/dta.70055}
}
EUVIMED